A report was received on (b)(6) 2017 from the caregiver of a (b)(6) male patient who stated the patient reported shortness of breath following a standard hemodialysis treatment on (b)(6) 2017.The patient was hospitalized on (b)(6) 2017 and received hemodialysis to remove excess fluid.Additional information received on august 4, 2017 from the director of home therapies at the facility, stated the hospitalization for fluid removal was related to patients non-compliance and unrelated to nxstage products or therapy.Follow-up information received on august 10, 2017 from the staff at the facility indicated that the patient was released from hospital on (b)(6) 2017 and is continuing standard home hemodialysis without issue.The patient's comorbidities included end stage renal disease, hypertension, hyperlipidemia, and type ii diabetes mellitus.Despite the patient¿s comorbidities a relationship to nxstage products could not be ruled out by the patient¿s physician.
|